Kyung Jin Seo

Prof. Dr. Kyung Jin Seo

catholic university, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2023 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
RBReshmee Bhattacharya
Reshmee Bhattacharya
MAMohammad Rizwan Alam
Mohammad Rizwan Alam
MKMohammad Azhar Kamal
Mohammad Azhar Kamal
KSKyung Jin Seo
Kyung Jin Seo
LSLaishram Rajendrakumar Singh
Laishram Rajendrakumar Singh
Advanced glycation end-products (AGEs; e.g., glyoxal, methylglyoxal or carboxymethyl-lysine) are heterogenous group of toxic compounds synthesized in the body through both exogenous and endogenous pathways. AGEs are known to covalently modify proteins bringing about loss of functional alteration in the proteins. AGEs also interact with their receptor, receptor for AGE (RAGE) and such interactions influence different biological processes including oxidative stress and apoptosis. Previously, AGE-RAGE axis has long been considered to be the maligning factor for various human diseases including, diabetes, obesity, cardiovascular, aging, etc. Recent developments have revealed the involvement of AGE-RAGE axis in different pathological consequences associated with the onset of neurodegeneration including, disruption of blood brain barrier, neuroinflammation, remodeling of extracellular matrix, dysregulation of polyol pathway and antioxidant enzymes, etc. In the present article, we attempted to describe a new avenue that AGE-RAGE axis culminates to different pathological consequences in brain and therefore, is a central instigating component to several neurodegenerative diseases (NGDs). We also invoke that specific inhibitors of TIR domains of TLR or RAGE receptors are crucial molecules for the therapeutic intervention of NGDs. Clinical perspectives have also been appropriately discussed.

24 June 2024 in Thyroid®
Verified
Journal Article
Closed access
YLYujin Lee
Yujin Lee
MAMohammad Rizwan Alam
Mohammad Rizwan Alam
HPHongsik Park
Hongsik Park
Kwangil YimKwangil Yim
Kwangil Yim
KSKyung Jin Seo
Kyung Jin Seo
HCHyun Joo Choi
Hyun Joo Choi
Background: Artificial intelligence (AI) is increasingly being applied in pathology and cytology, showing promising results. We collected a large dataset of whole slide images (WSIs) of thyroid fine-needle aspiration cytology (FNA), incorporating z-stacking, from institutions across the nation to develop an AI model. Methods: We conducted a multicenter retrospective diagnostic accuracy study using thyroid FNA dataset from the Open AI Dataset Project that consists of digitalized images samples collected from 3 university hospitals and 215 Korean institutions through extensive quality check during the case selection, scanning, labeling, and reviewing process. Multiple z-layer images were captured using three different scanners and image patches were extracted from WSIs and resized after focus fusion and color normalization. We pretested six AI models, determining Inception ResNet v2 as the best model using a subset of dataset, and subsequently tested the final model with total datasets. Additionally, we compared the performance of AI and cytopathologists using randomly selected 1031 image patches and reevaluated the cytopathologists’ performance after reference to AI results. Results: A total of 10,332 image patches from 306 thyroid FNAs, comprising 78 malignant (papillary thyroid carcinoma) and 228 benign from 86 institutions were used for the AI training. Inception ResNet v2 achieved highest accuracy of 99.7%, 97.7%, and 94.9% for training, validation, and test dataset, respectively (sensitivity 99.9%, 99.6%, and 100% and specificity 99.6%, 96.4%, and 90.4% for training, validation, and test dataset, respectively). In the comparison between AI and human, AI model showed higher accuracy and specificity than the average expert cytopathologists beyond the two-standard deviation (accuracy 99.71% [95% confidence interval (CI), 99.38–100.00%] vs. 88.91% [95% CI, 86.99–90.83%], sensitivity 99.81% [95% CI, 99.54–100.00%] vs. 87.26% [95% CI, 85.22–89.30%], and specificity 99.61% [95% CI, 99.23–99.99%] vs. 90.58% [95% CI, 88.80–92.36%]). Moreover, after referring to the AI results, the performance of all the experts (accuracy 96%, 95%, and 96%, respectively) and the diagnostic agreement (from 0.64 to 0.84) increased. Conclusions: These results suggest that the application of AI technology to thyroid FNA cytology may improve the diagnostic accuracy as well as intra- and inter-observer variability among pathologists. Further confirmatory research is needed.

1 January 2007 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JYJinyoung Yoo
Jinyoung Yoo
JJJi Han Jung
Ji Han Jung
MLMyung A Lee
Myung A Lee
KSKyung Jin Seo
Kyung Jin Seo
BSByoung Yong Shim
Byoung Yong Shim
HKHoon Kyo Kim
Hoon Kyo Kim
Yoo J, et al. J Korean Med Sci. 2007 Apr;22(2):318-325. http://dx.doi.org/10.3346/jkms.2007.22.2.318

13 July 2023 in Cells
Verified
Journal Article
Open access
PDF file
HPHong Sik Park
Hong Sik Park
Yosep ChongYosep Chong
Yosep Chong
YLYujin Lee
Yujin Lee
Kwangil YimKwangil Yim
Kwangil Yim
KSKyung Jin Seo
Kyung Jin Seo
HCHyun Joo Choi
Hyun Joo Choi
A Pleural effusion cytology is vital for treating metastatic breast cancer; however, concerns have arisen regarding the low accuracy and inter-observer variability in cytologic diagnosis. Although artificial intelligence-based image analysis has shown promise in cytopathology research, its application in diagnosing breast cancer in pleural fluid remains unexplored. To overcome these limitations, we evaluate the diagnostic accuracy of an artificial intelligence-based model using a large collection of cytopathological slides, to detect the malignant pleural effusion cytology associated with breast cancer. This study includes a total of 569 cytological slides of malignant pleural effusion of metastatic breast cancer from various institutions. We extracted 34,221 augmented image patches from whole-slide images and trained and validated a deep convolutional neural network model (DCNN) (Inception-ResNet-V2) with the images. Using this model, we classified 845 randomly selected patches, which were reviewed by three pathologists to compare their accuracy. The DCNN model outperforms the pathologists by demonstrating higher accuracy, sensitivity, and specificity compared to the pathologists (81.1% vs. 68.7%, 95.0% vs. 72.5%, and 98.6% vs. 88.9%, respectively). The pathologists reviewed the discordant cases of DCNN. After re-examination, the average accuracy, sensitivity, and specificity of the pathologists improved to 87.9, 80.2, and 95.7%, respectively. This study shows that DCNN can accurately diagnose malignant pleural effusion cytology in breast cancer and has the potential to support pathologists.

1 January 2015 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SKSung Jeep Kim
Sung Jeep Kim
YKYong Seok Kim
Yong Seok Kim
EJEun Duok Jang
Eun Duok Jang
KSKyung Jin Seo
Kyung Jin Seo
JKJeong Soo Kim
Jeong Soo Kim
Kim SJ, et al. J Breast Cancer. 2015 Dec;18(4):347-355. http://dx.doi.org/10.4048/jbc.2015.18.4.347

4 June 2012 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HLHan Hong Lee
Han Hong Lee
KSKyung Jin Seo
Kyung Jin Seo
CAChang Hyeok An
Chang Hyeok An
JKJeong Soo Kim
Jeong Soo Kim
HJHae Myung Jeon
Hae Myung Jeon